FLT3 and acute myeloid leukemia: In FLT3-ITD+ AML, there is evidence that NOX4-derived ROS lead to oxidative inactivation of protein tyrosine phosphatase, receptor J—PTPRJ (PTPRJ) (Table 1), and that NOX4 knockdown restored phosphatase activity [81].